US 10280175
Hepatitis B antiviral agents
granted A61KA61K31/4178A61K31/435
Quick answer
US patent 10280175 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4178, A61K31/435, A61K31/438, A61K31/46